Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 62332-770

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 62332-770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets (Lamotrigine 100mg Bottle)

Label for Lamotrigine Orally Disintegrating Tablets, USP 100 mg oral dosage form by Alembic Pharmaceuticals Inc. The label includes dosage strength, NDC 62332-772-30, manufacturer details, a warning to verify product dispensed, and packaging information indicating 30 tablets per container. It also mentions storage conditions and child-resistant packaging.*

FDA Label Image

30 Tablets (Lamotrigine 100mg Carton)

Packaging label for Lamotrigine Orally Disintegrating Tablets, USP 100 mg by Alembic Pharmaceuticals Inc. The label indicates a maintenance pack containing 30 tablets (3 x 10 unit dose) with instructions emphasizing it is for patients already taking lamotrigine, not for initial titration. The label includes directions to open, pull, peel, and place the tablet, and caution to verify product dispensed.*

FDA Label Image

30 Tablets (Lamotrigine 200mg Bottle)

Lamotrigine Orally Disintegrating Tablets, USP 200 mg, in a label showing the product name, strength, dosage form, and manufacturer details. The label includes the NDC number 62332-773-30, directions to dispense the Medication Guide, storage instructions, child-resistant packaging information, and a barcode. The labeler is Alembic Pharmaceuticals Inc., with manufacturing details listed for Alembic Pharmaceuticals Limited in Gujarat, India, and Alembic Pharmaceuticals, Inc. in New Jersey, USA. The package contains 30 tablets.*

FDA Label Image

30 Tablets (Lamotrigine 200mg Carton)

Packaging label for Lamotrigine Orally Disintegrating Tablets, USP 200 mg Maintenance Pack by Alembic Pharmaceuticals Inc. The label includes dosage form, strength, quantity (30 tablets), usage instructions, and a caution to verify the product dispensed. It also describes the intended use for patients already taking Lamotrigine, not for initial titration.*

FDA Label Image

30 Tablets (Lamotrigine 25mg Bottle)

Lamotrigine Orally Disintegrating Tablets, USP 25 mg label from Alembic Pharmaceuticals Inc. Contains 30 tablets. The label notes storage instructions, manufacturer details, and caution to verify the product dispensed. Includes prescribing information reference and barcode details.*

FDA Label Image

30 Tablets (Lamotrigine 25mg Carton)

Packaging label for Lamotrigine Orally Disintegrating Tablets, USP 25 mg Maintenance Pack by Alembic Pharmaceuticals Inc. The label indicates it contains 30 tablets and is intended for patients already taking Lamotrigine, not for initial titration. The label includes dispensing instructions, a caution to verify the product dispensed, and illustrated steps for tablet use.*

FDA Label Image

30 Tablets (Lamotrigine 50mg Bottle)

Label for Lamotrigine Orally Disintegrating Tablets, USP 50 mg by Alembic Pharmaceuticals Inc. The label includes NDC 62332-771-30 and states the product is prescription-only with a 30-tablet count. Storage instructions and cautions for pharmacists and patients are present, along with manufacturer details and barcode.*

FDA Label Image

30 Tablets (Lamotrigine 50mg Carton)

Packaging label for Lamotrigine Maintenance Pack 50 mg orally disintegrating tablets by Alembic Pharmaceuticals Inc. The label features product name, strength, dosage form, and quantity (30 tablets). It includes instructions for use, caution to verify the product dispensed, and patient tips for taking the medication. The label also provides step-by-step directions to open the pack and consume the tablets without water.*

FDA Label Image

Lamotrigine-all-strength.jpg (Lamotrigine All Strength)

A text panel showing Lamotrigine orally disintegrating tablets in strengths of 25 mg, 50 mg, 100 mg, and 200 mg. Each tablet is white to off white and debossed with its strength number: "10" for 25 mg, "70" for 50 mg, "110" for 100 mg, and "770" for 200 mg.*

FDA Label Image

Lamotrigine-fig-1.jpg (Lamotrigine Fig 1)

A survival curve graph showing failure probability percentage over weeks comparing Lamotrigine with Placebo. The graph indicates failure probability on the vertical axis and time in weeks on the horizontal axis, with separate curves labeled for Lamotrigine and Placebo, and markers for censored data points.*

FDA Label Image

Lamotrigine-fig-2.jpg (Lamotrigine Fig 2)

A Kaplan-Meier curve showing failure probability (%) over weeks for Lamotrigine versus placebo. The graph displays two lines representing failure probability increasing over time, with censored data points marked. The placebo group shows a higher failure probability compared to the Lamotrigine group throughout the duration of approximately 80 weeks.*

FDA Label Image

Lamotrigine-structure.jpg (Lamotrigine Structure)

Chemical structure of lamotrigine, showing its molecular arrangement with chlorine atoms, amino groups, and a triazine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.